Skip to Main

Search

Results 821 to 830 of 938 for ""

Building a better breast: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/building-better-breast.html

Surgeons at UT Southwestern have developed a process to determine the best approach for single breast reconstruction.

Daylight saving returns amid global debate to end clock change: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/daylight-saving.html

Daylight saving is approaching again, perhaps for the penultimate time in some countries where a fierce debate is being waged over its impact on health and the economy.

Roughly 6,000 UT Southwestern caregivers receive COVID-19 vaccine: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/caregivers-receive-vaccine.html

Nearly 6,000 front-line health care workers at UT Southwestern have received initial doses of the COVID-19 vaccine since the Medical Center received its first shipment of 5,850 doses on Dec. 15.

UTSW cardiologist receives NIH Outstanding Investigator Award: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/january-nih-outstanding-investigator-award.html

UT Southwestern physician-scientist Hesham Sadek, M.D., Ph.D., has received the prestigious National Institutes of Health (NIH) Outstanding Investigator Award to support his ongoing research into mechanisms behind heart regeneration that could lead to treatments for heart failure.

Boosting the immune system's appetite for cancer - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/boosting-the-immune-systems-appetite-for-cancer.html

A combination of immunotherapy agents that encourages some immune cells to eat cancer cells and alert others to attack tumors put mice with a deadly type of brain cancer called glioblastoma into long-term remission

At UTSW, an innovative procedure offers new hope for amputees: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/feb-innovative-procedure-amputees.html

Complications after an amputation left Scott Bryson, a 50-year-old father of three, unable to walk. But in June 2023, he took his first steps in nearly a decade after receiving a revolutionary surgical procedure at UT Southwestern Medical Center.

Researchers uncover two-drug combo that halts the growth of cancer cells : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/two-drug-combo-cancer.html

A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.

A sole mate to prevent diabetic foot ulcers: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/diabetic-foot-ulcers.html

A new cooling insole developed by UT Southwestern scientists reduced the foot temperature of patients with diabetic neuropathy by several degrees, diminishing a significant risk factor for diabetic foot ulcers.

FDA-approved drugs could help fight COVID-19 - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/fda-approved-drugs-could-help-fight-covid19.html

Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold promise in fighting the new infection known as coronavirus disease 2019 (COVID-19)...

Drug combination could eliminate side effects of once-popular diabetes treatment: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/drug-combination-could-eliminate-diabetes-treatment-side-effects.html

Study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.